Slowing the pace of India’s mucormycosis threat

News Today 26.05.2021

The alarming rise in India recently in the incidence of mucormycosis — a rare fungal infection — in patients who have been diagnosed and treated for COVID-19 has come as no surprise to those of us in the medical oncology community. This outcome was our greatest fear as the administration of dexamethasone and other steroids began to become common. (Read More)


Be the first to comment

Leave a Reply

Your email address will not be published.